NCT03070392 2026-03-17Safety and Efficacy of IMCgp100 Versus Investigator Choice in Advanced Uveal MelanomaImmunocore LtdPhase 2 Completed378 enrolled 15 charts 1 FDA
NCT06346067 2026-02-27A Study to Assess Naporafenib (ERAS-254) Administered With Trametinib in Patients With NRAS-mutant Melanoma (SEACRAFT-2)Erasca, Inc.Phase 3 Active not recruiting78 enrolled